Literature DB >> 28472294

Disrupted-in-Schizophrenia-1 (DISC1) protein disturbs neural function in multiple disease-risk pathways.

Lisha Shao1,2, Binyan Lu1,3, Zhexing Wen4, Shaolei Teng5, Lingling Wang1, Yi Zhao1, Liyuan Wang1, Koko Ishizuka6, Xiufeng Xu7, Akira Sawa6, Hongjun Song4, Guoli Ming4, Yi Zhong1,8.   

Abstract

Although the genetic contribution is under debate, biological studies in multiple mouse models have suggested that the Disrupted-in-Schizophrenia-1 (DISC1) protein may contribute to susceptibility to psychiatric disorders. In the present study, we took the advantages of the Drosophila model to dissect the molecular pathways that can be affected by DISC1 in the context of pathology-related phenotypes. We found that three pathways that include the homologs of Drosophila Dys, Trio, and Shot were downregulated by introducing a C-terminal truncated mutant DISC1. Consistently, these three molecules were downregulated in the induced pluripotent stem cell-derived forebrain neurons from the subjects carrying a frameshift deletion in DISC1 C-terminus. Importantly, the three pathways were underscored in the pathophysiology of psychiatric disorders in bioinformatics analysis. Taken together, our findings are in line with the polygenic theory of psychiatric disorders.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28472294      PMCID: PMC5886174          DOI: 10.1093/hmg/ddx147

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  61 in total

1.  Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.

Authors:  Takatoshi Hikida; Hanna Jaaro-Peled; Saurav Seshadri; Kenichi Oishi; Caroline Hookway; Stephanie Kong; Di Wu; Rong Xue; Manuella Andradé; Stephanie Tankou; Susumu Mori; Michela Gallagher; Koko Ishizuka; Mikhail Pletnikov; Satoshi Kida; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

2.  Abnormal wake/sleep pattern in a novel gain-of-function model of DISC1.

Authors:  Hanna Jaaro-Peled; Cara Altimus; Tara LeGates; Tyler Cash-Padgett; Sandra Zoubovsky; Takatoshi Hikida; Koko Ishizuka; Samer Hattar; Valérie Mongrain; Akira Sawa
Journal:  Neurosci Res       Date:  2016-06-26       Impact factor: 3.304

3.  Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain.

Authors:  Woraphat Ratta-Apha; Akitoyo Hishimoto; Kentaro Mouri; Kyoichi Shiroiwa; Toru Sasada; Masakuni Yoshida; Irwan Supriyanto; Yasuhiro Ueno; Migiwa Asano; Osamu Shirakawa; Hideru Togashi; Yoshimi Takai; Ichiro Sora
Journal:  Neurosci Res       Date:  2013-09-04       Impact factor: 3.304

4.  Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia.

Authors:  J K Millar; S Christie; S Anderson; D Lawson; D Hsiao-Wei Loh; R S Devon; B Arveiler; W J Muir; D H Blackwood; D J Porteous
Journal:  Mol Psychiatry       Date:  2001-03       Impact factor: 15.992

5.  Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology.

Authors:  Bagrat Abazyan; Jun Nomura; Geetha Kannan; Koko Ishizuka; Kellie L Tamashiro; Frederick Nucifora; Vladimir Pogorelov; Bruce Ladenheim; Chunxia Yang; Irina N Krasnova; Jean Lud Cadet; Carlos Pardo; Susumu Mori; Atsushi Kamiya; Michael W Vogel; Akira Sawa; Christopher A Ross; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2010-12-15       Impact factor: 13.382

6.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

7.  Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling.

Authors:  Yingwei Mao; Xuecai Ge; Christopher L Frank; Jon M Madison; Angela N Koehler; Mary Kathryn Doud; Carlos Tassa; Erin M Berry; Takahiro Soda; Karun K Singh; Travis Biechele; Tracey L Petryshen; Randall T Moon; Stephen J Haggarty; Li-Huei Tsai
Journal:  Cell       Date:  2009-03-20       Impact factor: 41.582

8.  Genome-wide association study identifies five new schizophrenia loci.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

9.  Genic intolerance to functional variation and the interpretation of personal genomes.

Authors:  Slavé Petrovski; Quanli Wang; Erin L Heinzen; Andrew S Allen; David B Goldstein
Journal:  PLoS Genet       Date:  2013-08-22       Impact factor: 5.917

Review 10.  Drosophila tools and assays for the study of human diseases.

Authors:  Berrak Ugur; Kuchuan Chen; Hugo J Bellen
Journal:  Dis Model Mech       Date:  2016-03       Impact factor: 5.758

View more
  10 in total

1.  Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia.

Authors:  Eduard Bentea; Erica A K Depasquale; Sinead M O'Donovan; Courtney R Sullivan; Micah Simmons; James H Meador-Woodruff; Ying Zhou; Chongchong Xu; Bing Bai; Junmin Peng; Hongjun Song; Guo-Li Ming; Jarek Meller; Zhexing Wen; Robert E McCullumsmith
Journal:  Mol Omics       Date:  2019-06-10

2.  CA1 Spike Timing is Impaired in the 129S Inbred Strain During Cognitive Tasks.

Authors:  Tolulope Adeyelu; Amita Shrestha; Philip A Adeniyi; Charles C Lee; Olalekan M Ogundele
Journal:  Neuroscience       Date:  2021-11-17       Impact factor: 3.590

Review 3.  Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia.

Authors:  Silas A Buck; M Quincy Erickson-Oberg; Ryan W Logan; Zachary Freyberg
Journal:  Mol Psychiatry       Date:  2022-06-10       Impact factor: 13.437

Review 4.  Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update.

Authors:  Jasmina Dimitrova-Shumkovska; Ljupcho Krstanoski; Leo Veenman
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

5.  Disc1 Carrier Mice Exhibit Alterations in Neural pIGF-1Rβ and Related Kinase Expression.

Authors:  Razia Sultana; Amita Shrestha; Charles C Lee; Olalekan M Ogundele
Journal:  Front Cell Neurosci       Date:  2020-05-05       Impact factor: 5.505

6.  Altered White Matter and Layer VIb Neurons in Heterozygous Disc1 Mutant, a Mouse Model of Schizophrenia.

Authors:  Shin-Hwa Tsai; Chih-Yu Tsao; Li-Jen Lee
Journal:  Front Neuroanat       Date:  2020-12-15       Impact factor: 3.856

7.  Genetic interaction of DISC1 and Neurexin in the development of fruit fly glutamatergic synapses.

Authors:  Himani Pandey; Katia Bourahmoune; Takato Honda; Ken Honjo; Kazuki Kurita; Tomohito Sato; Akira Sawa; Katsuo Furukubo-Tokunaga
Journal:  NPJ Schizophr       Date:  2017-10-27

Review 8.  The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions.

Authors:  Yu-Ting Weng; Ting Chien; I-I Kuan; Yijuang Chern
Journal:  J Biomed Sci       Date:  2018-10-04       Impact factor: 8.410

9.  Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics.

Authors:  João V Nani; Richard S Lee; Camila M Yonamine; Osvaldo A Sant'Anna; Maria A Juliano; Ary Gadelha; Jair J Mari; Mirian A F Hayashi
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

10.  Structural interaction between DISC1 and ATF4 underlying transcriptional and synaptic dysregulation in an iPSC model of mental disorders.

Authors:  Xinyuan Wang; Fei Ye; Zhexing Wen; Ziyuan Guo; Chuan Yu; Wei-Kai Huang; Francisca Rojas Ringeling; Yijing Su; Wei Zheng; Guomin Zhou; Kimberly M Christian; Hongjun Song; Mingjie Zhang; Guo-Li Ming
Journal:  Mol Psychiatry       Date:  2019-08-23       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.